SEC Form 4 · accession 0001127602-15-008727
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2015
Accepted (ET)
Feb 27, 2015 · 9:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2015 | S | 100 | $76.33 | D | 355,362 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.34 | D | 355,162 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.36 | D | 355,062 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.37 | D | 354,962 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.38 | D | 354,862 | D | |
| Common Stock | Feb 25, 2015 | S | 500 | $76.39 | D | 354,362 | D | |
| Common Stock | Feb 25, 2015 | S | 400 | $76.40 | D | 353,962 | D | |
| Common Stock | Feb 25, 2015 | S | 500 | $76.41 | D | 353,462 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.4175 | D | 353,362 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.42 | D | 353,162 | D | |
| Common Stock | Feb 25, 2015 | S | 1,100 | $76.44 | D | 352,062 | D | |
| Common Stock | Feb 25, 2015 | S | 320 | $76.45 | D | 351,742 | D | |
| Common Stock | Feb 25, 2015 | S | 300 | $76.455 | D | 351,442 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.46 | D | 351,242 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.47 | D | 351,042 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.475 | D | 350,842 | D | |
| Common Stock | Feb 25, 2015 | S | 300 | $76.48 | D | 350,542 | D | |
| Common Stock | Feb 25, 2015 | S | 882 | $76.49 | D | 349,660 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.50 | D | 349,460 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.505 | D | 349,360 | D | |
| Common Stock | Feb 25, 2015 | S | 26 | $76.51 | D | 349,334 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.515 | D | 349,234 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.5175 | D | 349,134 | D | |
| Common Stock | Feb 25, 2015 | S | 134 | $76.52 | D | 349,000 | D | |
| Common Stock | Feb 25, 2015 | S | 438 | $76.53 | D | 348,562 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.535 | D | 348,462 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.